CSIMarket
 
Quidelortho Corp  (NASDAQ: QDEL)
Other Ticker:  
 
 
Price: $41.1700 $-0.30 -0.723%
Day's High: $41.28 Week Perf: -2.21 %
Day's Low: $ 40.87 30 Day Perf: -7.71 %
Volume (M): 12 52 Wk High: $ 68.85
Volume (M$): $ 478 52 Wk Avg: $41.86
Open: $40.96 52 Wk Low: $29.74



 Market Capitalization (Millions $) 2,771
 Shares Outstanding (Millions) 67
 Employees 3,000
 Revenues (TTM) (Millions $) 2,818
 Net Income (TTM) (Millions $) -1,867
 Cash Flow (TTM) (Millions $) -6
 Capital Exp. (TTM) (Millions $) 197

Quidelortho Corp
Quidelortho Corp is a medical device manufacturing company that is primarily engaged in the production of orthodontic products.
The company was founded in 2005 and is based in San Diego, California, USA.
The main products of Quidelortho Corp include brackets, wires, bands, and other orthodontic accessories.
The company aims to provide high-quality and affordable orthodontic products to practitioners around the world.
Quidelortho Corp prides itself in the use of the latest technology and research to develop its products.
The company has a team of experienced professionals who have vast knowledge and practical experience in the orthodontic field.
The products manufactured by Quidelortho Corp are designed to meet the diverse needs of orthodontic practitioners.
The company offers a wide range of products to help practitioners provide effective orthodontic treatment to their patients.
In addition to manufacturing orthodontic products, Quidelortho Corp offers training and support to orthodontic practitioners.
The company offers seminars, workshops, and webinars to help practitioners understand the latest trends and techniques in orthodontic treatment.
Overall, Quidelortho Corp is a leading manufacturer of orthodontic products that is committed to providing high-quality products and training to orthodontic practitioners.
The company aims to make orthodontic treatment more accessible and affordable to people around the world.


   Company Address: 9975 Summers Ridge Road San Diego 92121 CA
   Company Phone Number: 552-1100   Stock Exchange / Ticker: NASDAQ QDEL


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BMRA        48.29% 
ABT        1.82% 
BDX        0.04% 
DHC   -0.38%    
DHR   -5.44%    
HOLX   -11.44%    
• View Complete Report
   



Business Update

Navigating Innovation Amid Financial Challenges QuidelOrtho?s VITROS Syphilis Assay Gains FDA Clearance,

Published Thu, Aug 29 2024 11:47 AM UTC

SAN DIEGO QuidelOrtho Corporation (Nasdaq: QDEL) (QuidelOrtho) has recently achieved a significant regulatory milestone that could enhance its position in the healthcare diagnostics market. The company received U.S. Food and Drug Administration (FDA) 510(k) clearance for its VITROS Syphilis Assay. This approval allows the syphilis assay to be included in the diagnostic te...

Stocks on the Move

A New Look at QuidelOrtho Corporation (QDEL) Stocks Hidden Strategies

Published Fri, Jul 19 2024 8:39 PM UTC

QuidelOrtho Corporation Reports Strong Second Quarter 2024 Financial Results Amidst Market ChallengesQuidelOrtho Corporation (Nasdaq: QDEL), a global provider of innovative in vitro diagnostic technologies, has announced its second quarter 2024 financial results, defying market expectations amidst ongoing challenges. The company has demonstrated resilience, maintaining its p...

Stocks on the Move

Thyroid Disorders Understanding the Connection with Your Metabolism, Mood, and More

Published Tue, Jul 9 2024 4:32 PM UTC

Thyroid disorders continue to affect millions of people worldwide, often with hidden symptoms that can significantly impact their overall well-being. In this article, we will explore the insights shared by Jeff Houtz, the Global Product Manager for Thyroid Products and Reproductive Endocrinology at QuidelOrtho, shedding light on various thyroid tests and the lesser-known sym...

Stocks on the Move

Unveiling the QuidelOrtho Investor Claims Revealing Stock Drop and Corporate Governance Issues

Published Tue, Jun 25 2024 12:21 PM UTC

(approx. 100 words):In recent events, QuidelOrtho, a prominent healthcare company, experienced a significant drop in stock prices after claims were filed by investors. As a result, many questions have been raised regarding potential corporate governance issues within the company. This article aims to examine the events that led to the drop in stock prices, analyze the claim...

Announcement

Major Legal Battle Unfolds as Pomerantz and Rosen Law Firms Announce Class Action Lawsu...

Published Tue, May 28 2024 3:16 PM UTC

Major Legal Battle Unfolds as Pomerantz and Rosen Law Firms Announce Class Action Lawsuits Against QuidelOrtho Corporation (QDEL)In a significant development within the corporate and legal communities, QuidelOrtho Corporation (NASDAQ: QDEL) finds itself at the epicenter of two major class action lawsuits. These legal actions, spearheaded by Pomerantz LLP and Rosen Law Firm,...







Quidelortho's Segments
Labs    48.95 % of total Revenue
Immunohematology    18.15 % of total Revenue
Donor Screening    3.85 % of total Revenue
Point of Care    28.28 % of total Revenue
Molecular Diagnostics    0.77 % of total Revenue
North America    59.99 % of total Revenue
EMEA    11.55 % of total Revenue
China    11.06 % of total Revenue
Other    17.4 % of total Revenue





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com